Franken questions the necessity of actuarial studies for CCRCs.
07/20/2010
https://www.congress.gov...
I would urge you please to do that as soon as possible.
You would think you would need three and a half times as many as normal population.
It's profoundly unfair that we continue to pay so much more for the same drugs.
Direct negotiation by the government with drug manufacturers would result in a significant reduction in the cost of Part D drugs.